Table 2.
Comparison of 28-Day Mortality According to Treatment Group.*
| Variable | Current Standard of Care Alone | Current Standard of Care plus ZMapp | Bayesian Estimate of Absolute Difference | Bayesian Estimate of Relative Risk | Posterior Probability That ZMapp Was Superior |
|---|---|---|---|---|---|
| percentage points (95% CI) | value (95% CI) | % | |||
| No. of patients alive | 22 | 28 | |||
|
| |||||
| No. of patients who died | 13 | 8 | |||
|
| |||||
| No. of patients lost to follow-up | 1 | 0 | |||
|
| |||||
| 28-Day mortality — % | 37† | 22† | −14 (−34 to 6) | 0.62 (0.29 to 1.24) | 91.2 |
CI denotes credible interval.
These are crude non-Bayesian estimates.